TriReme Medical Cleared In Catheter IP Trial, Attys Say
A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme's vascular stent did not infringe its competitor,...To view the full article, register now.
Already a subscriber? Click here to view full article